p16-positive oropharyngeal cancer with rare thyroid metastasis : A case report

J Med Invest. 2020;67(1.2):189-191. doi: 10.2152/jmi.67.189.

Abstract

Thyroid metastasis is rarely diagnosed, and the treatment outcomes in p16-positive oropharyngeal squamous cell carcinoma patients with rare thyroid metastasis have not been fully investigated. Here we describe the case of a patient with p16-positive oropharyngeal squamous cell carcinoma who was diagnosed with cT4 N2M1 with rare thyroid metastasis. The patient was a current smoker and was positive for human papillomavirus DNA, with disease progression at 49 days and death at 113 days after completion of cisplatin-based concurrent chemoradiotherapy. J. Med. Invest. 67 : 189-191, February, 2020.

Keywords: HPV-DNA; oropharyngeal squamous cell carcinoma; p16-positive; smoking status; thyroid metastasis.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Alphapapillomavirus / isolation & purification
  • Chemoradiotherapy
  • Cyclin-Dependent Kinase Inhibitor p16 / analysis*
  • DNA, Viral / analysis
  • Humans
  • Male
  • Oropharyngeal Neoplasms / pathology*
  • Squamous Cell Carcinoma of Head and Neck / pathology*
  • Thyroid Neoplasms / secondary*
  • Thyroid Neoplasms / therapy

Substances

  • CDKN2A protein, human
  • Cyclin-Dependent Kinase Inhibitor p16
  • DNA, Viral